Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Part I: To confirm that the combination of PF-04856884 and AG-013736 is safe and tolerable at the doses to be used in Part II of the study. Part II: To document clinical activity of the combination of PF-04856884 and AG-013736 or AG-013736 alone as measured by PFS in adult patients with previously treated mRCC.
Inclusion criteria
- Metastatic Renal Cell Carcinoma